Anzeige
Mehr »
Donnerstag, 15.05.2025 - Börsentäglich über 12.000 News
Verpasst du gerade die Buffett-Aktie der neuen Generation?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Dow Jones News
2.446 Leser
Artikel bewerten:
(2)

bonyf NV: Annual Results 2021

Finanznachrichten News

DJ bonyf NV: ANNUAL RESULTS 2021

bonyf NV bonyf NV: ANNUAL RESULTS 2021 30-Jun-2022 / 19:00 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.

-----------------------------------------------------------------------------------------------------------------------

Annual results 2021

-- 14.2% growth in revenue to EUR2,710K (vs. EUR2,372K in the fiscal year 2020), reflecting a good level ofactivity despite the effects of the pandemic

-- Operating income at (EUR80K), taking into account the strong increase in marketing investments to developfuture sales of the leading products PerioTabs® and OlivaFix® Gold

Confidence in continued growth in 2022 Ghent (Belgium), 30 June, 2022, 7 p.m.; bonyf NV (ticker symbol: MLBON), the next-generation oral comfort expert, presents its 2021 financial statements, approved by its Board of Directors and audited by its Statutory Auditors.

In EURK 
         2021 2020 Variation 
Audited data 
Sales Revenue   2,710 2,372 +14.2% 
Gross margin   2,028 1,657 +22.4% 
Operating income (80) (67) -19.8% 
Net income    (133) (70) - 

Resumption of growth in 2021

After the fiscal year 2020 was heavily impacted by the health crisis, bonyf achieved a 14.2% increase in revenues to EUR2,710K in 2021. This was driven by the gradual return to normal economic activity of its main distributors. Growth was still slow in some countries, due to delays in the resumption of supplies and continued closure of certain regions for part of the year.

Gross margin improvement and increased marketing investments

In the fiscal year 2021, bonyf maintained a high-level gross margin of EUR2,028K, giving a gross margin rate of 74.8% compared with 69.9% in 2020.

bonyf has amplified its marketing efforts in 2021 in order to relaunch the post-Covid sales momentum and promote its products in new geographical areas. An exceptional investment was made in the last quarter of 2021 in Italy to increase sales of its flagship product, PerioTabs®, a strategic geographic area for bonyf.

bonyf also incurred substantial non-current expenses related to the proposed listing of bonyf NV, which took place last March.

As a result of these specific costs, the operating income shows a slight annual loss of EUR80K close to the one recorded in 2020. After taking into account the financial expense of EUR50K and income tax of EUR3K, the net result is a deficit of EUR133K in 2021.

Balanced financial structure

As of 31 December 2021, bonyf's shareholders' equity amounted to EUR209K. Taking into account a gross debt of EUR230K and an active cash flow of EUR156K, the net debt amounts to EUR74K; 35% of the equity.

Favourable outlook for 2022

The announced conquest of new markets in Asia, the planned launch of new products and the ramping up of its two flagship products will contribute to achieving this objective in 2022.

bonyf's listing on Euronext Access has already raised the group's profile and will enable them to raise funds to finance the growth expected in the coming years.

bonyf's strengths . Products with patented formulations . Produced in Switzerland compliant with stringent international quality regulations . Proven clinical efficacy . Commercial presence in 37 countries . Prospects for solid growth and rapid profitability . A fast-growing oral and dental care market

About bonyf

Incorporated in 1979, bonyf specialises in the development, production and selling of cutting-edge oral & dental care products. Through its unwavering commitment to innovation and continuous improvement, bonyf makes a real difference to people suffering from dental and oral conditions. The Company has its R&D facilities in Liechtenstein (in the renown dental valley), a production plant in Switzerland and distributes its product range in 36 countries worldwide. Benefiting from seven patent protected formulations and products developed in-house, bonyf expects strong future development, driven by the fast-growing oral and dental care market.

Learn more at https://bonyf.com

bonyf Jean-Pierre Bogaert investor@bonyf.com Press Relations CapValue info@capvalue.fr +33 1 80 81 50 00

-----------------------------------------------------------------------------------------------------------------------

Regulatory filing PDF file File: BONYF: ANNUAL RESULTS 2021

=---------------------------------------------------------------------- 
Language:    English 
Company:     bonyf NV 
         Doornzelestraat 114 D 
         9000 Gent 
         Belgium 
Phone:      +41 79 412 42 79 
E-mail:     president@bonyf.com 
Internet:    www.bonyf.com 
ISIN:      BE6333353298 
Euronext Ticker: MLBON 
AMF Category:  Inside information / News release on accounts, results 
EQS News ID:   1388249 
 
End of Announcement EQS News Service 
=------------------------------------------------------------------------------------ 

1388249 30-Jun-2022 CET/CEST

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1388249&application_name=news

(END) Dow Jones Newswires

June 30, 2022 13:00 ET (17:00 GMT)

© 2022 Dow Jones News
Die USA haben fertig! 5 Aktien für den China-Boom
Die Finanzwelt ist im Umbruch! Nach Jahren der Dominanz erschüttert Donald Trumps erratische Wirtschaftspolitik das Fundament des amerikanischen Kapitalismus. Handelskriege, Rekordzölle und politische Isolation haben eine Kapitalflucht historischen Ausmaßes ausgelöst.

Milliarden strömen aus den USA – und suchen neue, lukrative Ziele. Und genau hier kommt China ins Spiel. Trotz aller Spannungen wächst die chinesische Wirtschaft dynamisch weiter, Innovation und Digitalisierung treiben die Märkte an.

Im kostenlosen Spezialreport stellen wir Ihnen 5 Aktien aus China vor, die vom US-Niedergang profitieren und das Potenzial haben, den Markt regelrecht zu überflügeln. Wer jetzt klug investiert, sichert sich den Zugang zu den neuen Wachstums-Champions von morgen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche 5 Aktien die Konkurrenz aus den USA outperformen dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.